Key result
Early gene-panel sequencing identifies a MYOT variant in progressive proximal weakness despite normal standard testing.
Case Report (n=1)
MYOT myopathy can present with preserved enzyme levels and normal electrodiagnostic studies, highlighting the importance of early gene-panel sequencing to expedite diagnosis and guide cardiac surveillance.
A man in his 60s presented with progressive, symmetric weakness of the shoulder and thigh girdles despite normal creatine kinase and electromyography findings. Lumbar spine MRI revealed only age-appropriate degenerative changes, insufficient to explain his symptoms. A targeted 60-gene next-generation sequencing panel identified a heterozygous MYOT c.179C>T (p.Ser60Phe) variant, confirming MYOT -related myofibrillar myopathy. Cardiac evaluation demonstrated mild aortic-root dilatation, mitral regurgitation and frequent premature atrial contractions. The patient underwent supervised eccentric-strengthening physiotherapy with stable function over 1 year. This case underscores that MYOT myopathy can present with preserved enzyme levels and normal electrodiagnostic studies, risking diagnostic delay if clinicians rely solely on conventional testing. Early gene-panel sequencing in patients with unexplained proximal weakness can expedite diagnosis, guide cardiac surveillance and inform family cascade testing.
No takes yet. Share an insight, caveat, or question.
Viradia et al. (2026) conducted a case report in MYOT-related myofibrillar myopathy (n=1). Targeted 60-gene next-generation sequencing panel was evaluated. Early gene-panel sequencing identified a heterozygous MYOT c.179C>T variant in a man with progressive proximal weakness despite normal creatine kinase and electromyography.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: